T1	Participants 335 369	early stages of mycosis fungoides.
T2	Participants 569 624	patients treated with PUVA alone or PUVA and bexarotene
T3	Participants 767 821	patients with stage IB and IIA mycosis fungoides (MF).
T4	Participants 1002 1029	93 of 145 required patients
T5	Participants 1060 1083	93 randomized patients,